Abstract:The microtubule-associated Tau protein aggregates into insoluble paired helical filaments (PHFs) that deposit as neurofibrillary tangles (NFTs) which may cause neurodegeneration in brains of those with Alzheimer's disease(AD) and other related tauopathies; therefore, the drug discovery targeting on Tau protein has attracted an increasing number of researchers. In the last decade, most of the studies were focused on the approach to search for inhibitors of phosphorylation kniases, while only few put their eyes on the approach to discover inhibitors of Tau self-aggregation process. Phenylthiazolyl-Hydrazide (PTH) with the same core structure is a kind of molecules that directly inhibit Tau self-aggregation process. To illuminate the relationship between the structure of R-groups and molecular activities, and design new molecules with higher activity than the template molecule, topomer CoMFA was employed in three-dimensional quantitative structure-activity relationship (3D-QSAR) studies of 26 phenylthiazolyl-hydrazides(PTH) derivatives as Tau protein inhibitors. The Topomer CoMFA model has good fitting ability and predictive ability. The number of principal components, r(2), q(2) r(pred)(2), SEE and F of the Topomer CoMFA model were 5, 0. 976, 0. 603, 0. 795, 0. 110 and 115. 778, respectively. The model was used to search R-groups with special activity contribution from ZINC database. By No. 1 molecule filtering, there were 9 R-1-groups and 2 R-2-groups with contribution values rising by 20%. We employed the 9 R-1-groups and 2 R-2-groups to alternately substitutes for the R-1 and R-2 of sample 1; as a result, we got a total of 18 new compounds and further predicted their activities using the Topomer CoMFA model obtained, and the activity of 15 of them were higher than that of the template molecule. This research showed that Topomer search could be effectively used in molecular design; meanwhile, the molecules designed provide new candidate drugs for drug development of Alzheimer's disease.

[Application of an R-group Search Strategy into Three-Dimensional Quantitative Structure-Activity Relationship of HEA Beta-Secretase Inhibitors and Molecular Virtual Screening].

Comprehensive 3D-QSAR and Binding Mode of BACE-1 Inhibitors Using R-group Search and Molecular Docking

Design, Synthesis and Biological Evaluation of 2-Styryl-5-hydroxy-4-pyrone Derivatives and Analogues As Multiple Functional Agents with the Potential for the Treatment of Alzheimer's Disease.

Interaction Mechanism Exploration of Hea Derivatives As Bace1 Inhibitors by in Silico Analysis

Searching for the Multi-Target-Directed Ligands Against Alzheimer’s Disease: Discovery of Quinoxaline-Based Hybrid Compounds with AChE, H3R and BACE 1 Inhibitory Activities

Study on the Active Mechanism of Β-Secretase Inhibitors by Molecular Simulations.

3D-Qsar, Synthesis and in Vitro Evaluation Study on Dual Binding Site Inhibitors of Acetylcholinestrase

Three-Dimensional Quantitative Structure-Activity Relationship Analyses of A Series of Butenolide Eta Antagonists

Synthesis and Preliminary Evaluation of Peptidomimetic Inhibitors of Human Beta-Secretase

Robust and predictive 3D-QSAR models for predicting the activities of novel oxadiazole derivatives as multifunctional anti-Alzheimer agents

Virtual screening of lead compounds for the treatment of Alzheimer's disease based on multi-target strategy

Using docking to investigate mechanism of action of GSK-3α inhibitors

Design and Prediction of New Acetylcholinesterase Inhibitor Via Quantitative Structure Activity Relationship of Huprines Derivatives

Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease

Molecular Design of PTH Derivatives as Tau Protein Inhibitors Using R-Group Search Technology

Identification Of Novel Bace1 Inhibitors By Combination Of Pharmacophore Modeling, Structure-Based Design And In Vitro Assay

Three dimensional quantitative structure-activity relationship of DATA analogues as HIV-1 reverse transcriptase inhibitors

2D-SAR and 3D-QSAR analyses for acetylcholinesterase inhibitors

Discovery, Molecular Dynamic Simulation and Biological Evaluation of Structurally Diverse Cholinesterase Inhibitors with New Scaffold Through Shape-Based Pharmacophore Virtual Screening.

Identification of novel acetylcholinesterase inhibitors through 3D-QSAR, molecular docking, and molecular dynamics simulation targeting Alzheimer’s disease

Screening for New Agonists Against Alzheimers Disease